New treatments to improve heart healing after a heart attack

Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure

NIH-funded research Pennsylvania State Univ Hershey Med Ctr · NIH-10878724

This study is looking at how certain immune cells in your body can help your heart heal after a heart attack, with the goal of finding better ways to support recovery and improve heart function.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr NIH-funded
Lab location1 site (Hershey, United States)
Project IDNIH-10878724 on NIH RePORTER

What this research studies

This research investigates how immune responses, particularly T-lymphocytes, affect heart healing after a heart attack. It focuses on understanding the timing and mechanisms of these immune responses to find ways to modulate them for better recovery. By studying the changes in T-cells during the transition from acute heart attack to chronic heart failure, the researchers aim to identify specific targets for therapy that could improve heart function. The approach includes using animal models to explore the effects of manipulating these immune cells on heart healing.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have experienced a heart attack and are at risk of developing chronic heart failure.

Not a fit: Patients who have not had a heart attack or those with advanced heart failure may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance heart recovery and function after a heart attack.

How similar studies have performed: Previous research has shown promising results in manipulating immune responses to improve heart healing, indicating that this approach has potential for success.

Where this research is happening

Hershey, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.